An experienced main board plc executive director and non executive director in international companies across different sectors including FMCG (drinks industry), technology (biotech and electronic displays) and manufacturing (non woven textiles and power and data cables). More than 30 years public company experience at listed plc and Nasdaq companies including 20 years as an executive main board director CFO, and also experienced as a non executive director and audit committee chair.Daniel brings considerable experience from the life sciences sector having worked as an executive director of a dual listed biotech company, Xenova Group plc, and served as a non executive director at the BIA. He is currently a non executive director and Audit Committee Chair at Genome Research Ltd, CUH NHS Foundation Trust and BioCity Group Ltd and has recently been involved in several start up ventures including a Swiss based drug development company. Executive career in a variety of international large, small and mid cap companies. Extensive experience of change management and turnarounds, as well as mergers and acquistions, and fundraising on capital markets and operating in developing markets including Asia, South America and Africa and Middle East as well as major developed markets. Executive CFO and main board director at Volex plc, Fiberweb plc, CDT Inc and Xenova Group plc. Senior finance roles include divisional CFO and VP Finance at PepsiCo and Head of Corporate Finance and Strategy at Diageo plc.Education. MA(Hons) Cambridge, barrister and member of Inner Temple, chartered accountant and FCA. Past panel member of the FRRP of the FRC and member of the IFT.